Amring Pharma Receives Supplier Horizon Award From Premier Inc.

BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. today announced that it is a recipient of the Supplier Horizon Award from Premier Inc., a leading healthcare improvement company.

One of 11 suppliers to receive the award this year, Amring Pharmaceuticals Inc. was recognized for its support of Premier members through exceptional local customer service and engagement, value creation through clinical excellence and commitment to lower costs.

“As a young company in an increasingly competitive industry, success and longevity rely on your ability to deliver on every promise, every time. I am proud of Amring’s steadfast commitment to putting people first and for making decisions that truly help our patients and customers,” said Daniel Carbery, Amring President and CEO. “Receiving this award humbles me and reminds me that even a young company can make a tremendous impact. Our continued focus will be on products and processes that improve the quality of health and life for the people we serve,” Carbery added.

Amring Pharmaceuticals Inc. accepted the award at Premier’s 2017 Breakthroughs Conference and Exhibition on June 29, 2017.

“Amring supports Premier members by offering valuable products and services that help to lower supply chain costs and improve operating efficiencies,” said Durral R. Gilbert, president of supply chain services, Premier. “We’re honored to recognize them a Horizon Award recipient.”

Horizon Award winners have tenure of less than three years as a Premier contracted supplier.

About Amring Pharmaceuticals Inc.

Amring Pharmaceuticals is a privately-held generic pharmaceutical company active in global markets geared to supplying unique and specialized products. The company is part of the global Amring Pharmaceuticals business and is partnered with well-established global biopharmaceutical companies. Amring is uniquely positioned to leverage its partners’ expertise in bringing biotechnology derived medicines, as well as patient-friendly drug delivery systems, sterile manufacturing and other state-of-the-art technologies to the marketplace.

About Premier Inc.

Premier Inc. is a leading healthcare improvement company, uniting an alliance of approximately 3,750 U.S. hospitals and more than 130,000 other provider organizations. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Please visit Premier’s news and investor sites on www.premierinc.com.

Safe Harbor

This press release contains forward-looking statements, including, without limitation, statements related to Amring’s business developments and the implementation of Amring’s strategic initiatives. Because these statements reflect Amring’s current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties that could cause actual developments and results to differ materially from Amring’s expectations. These factors include, but are not limited to, general market conditions, regulatory trends, changes in the financial conditions of third parties dealing with Amring, and other factors that could affect Amring’s business and financial performance. Amring does not assume any obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Amring Pharmaceuticals Inc.
Daniel Carbery, 610-285-7012
daniel.carbery@amringpharma.com

MORE ON THIS TOPIC